A fetus must be sheltered from any infl ammatory battle taking place in the mother. Now, Yeny Martinez de la Torre, Alberto Mantovani (University of Milan, Italy), and colleagues report that a decoy receptor in the placenta captures potentially dangerous pro-infl ammatory chemokines from the mother. This scavenging suppresses infl ammation and prevents fetal loss.
Decoy receptors such as the D6 receptor bind many infl ammatory chemokines without activating intracellular signaling. Instead, the receptor and chemokine are internalized and the chemokine is destroyed.
The Italian group confi rmed that D6 is expressed in the placenta, specifi cally on the apical side of syncytial trophoblasts. This is the side looking at the maternal blood and thus "a strategic location at the very interface between mother and fetus," says Mantovani.
To test the function of D6, the team injected pro-infl ammatory LPS. The response was greater in mice lacking D6: several infl ammatory chemokines built to higher levels in the circulation and placenta; more macrophages and T lymphocytes invaded the placenta; and there was more fetal loss.
Fetal loss may occur after a deadly positive feedback between infl ammation and blood clotting in the placenta. In the mice lacking D6, this can be prevented with an infusion of antichemokine antibodies. A similar blocking approach may be possible in some humans who suffer from recurrent fetal loss, although it is not yet clear whether changes in D6 function are implicated in any of these individuals. . The reduction appears to save energy-energy that can be put to work in fi xing life-threatening damage.
Protein translation rates decrease with age. Tavernarakis wondered if increased translation might increase turnover of damaged proteins and thus slow aging. But, he says, "what we found was the opposite."
The group knocked down the levels of IFE-2, one of the fi ve isoforms of the eIF4E translation initiation factor in worms. The development and eating patterns of the worms were normal, but they had an extended lifespan.
Other longevity-promoting pathways, such as the insulin and caloric restriction pathways, may modulate the eIF4E pathway (e.g., caloric restriction may reduce protein synthesis by down-regulating eIF4E). But ife-2 knockout was additive with mutation of these other pathways, suggesting that a simple linear relationship is unlikely.
Animals with less eIF4E had higher ATP levels and were more able to resist oxidative damage. "If we reduce the rate of protein synthesis we allow the cell to invest some extra energy in maintenance and repair functions," says Tavernarakis. "By repairing damage the cells can now survive for longer."
This benefi t is only relevant in the soma. In the germline, by contrast, translation is already near a minimum and a further reduction in eIF4E activity was lethal. "The germline invests in repair and maintenance but not so much in building," says Tavernarakis. "If we make our soma look a little more like our germline…then we might prolong the life of the soma."
